AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7586944
Drug: Buccal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buccal administration of 10 mg atipamezole hydrochloride
Trial: 7586944
Drug: Buccal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buccal administration of 20 mg atipamezole hydrochloride
Trial: 7586944
Drug: Buccal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buccal administration of 40 mg atipamezole hydrochloride
Trial: 7586944
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of 20 mg atipamezole hydrochloride
Trial: 7586944
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of 20 mg atipamezole hydrochloride
Trial: 31838561
Drug: Oral-VRL (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-VRL (60 mg/m2 for cycle 1, 80 mg/m2 for cycles 2-6) + EPI (75 mg/m2 on day 1 for all cycles)
Trial: 31838561
Drug: IV-VRL (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV-VRL (25 mg/m2 for cycle 1, 30 mg/m2 for cycles 2-6) + EPI (75 mg/m2 on day 1 for all cycles)
Trial: 27044546
Drug: Clarithromycin at
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin at 1 g daily for three consecutive days
Trial: 25540273
Drug: HPV-16/HPV-18 AS04-adjuvanted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV-16/HPV-18 AS04-adjuvanted vaccine
Trial: 16600938
Drug: High energy
RxNorm normalized name: High energy formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High energy density complementary foods (1.5 kcal/g)
Trial: 16600938
Drug: Low energy
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low energy density complementary foods (0.4 kcal/g)
Trial: 10807483
Drug: Titrated RUL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titrated RUL ECT at 2.25 times initial seizure threshold (mean dose, 136 mC)
Trial: 10807483
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose RUL ECT at 403 mC
Trial: 9026840
Drug: lovastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lovastatin (20 mg/day)
Trial: 8099492
Drug: alpha 1‐adrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha 1‐adrenergic blocker doxazosin (2 mg/day)
Trial: 22614285
Drug: Intravesical hyaluronic
RxNorm normalized name: hyaluronate
DrugBank: Hyaluronic acid (DB08818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravesical hyaluronic acid (HA) 800 mg and chondroitin sulfate (CS) 1 g in 50 mL of saline solution once weekly for 4 weeks then once every 2 weeks twice more (group 1)
Trial: 22614285
Drug: Long term
RxNorm normalized name: BENZETHONIUM CHLORIDE 0.12 g in 100 mL TOPICAL SOLUTION [CA-REZZ - LONG TERM CARE - INCONTINENT CLEANSER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long term antibiotic prophylaxis using sulfamethoxazole 200 mg and trimethoprim 40 mg once weekly for 6 weeks (group 2; control)
Trial: 18713150
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antimicrobial treatment)
Trial: 11752105
Drug: Edrophonium (0.01-1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium (0.01-1.0 mg/kg)
Trial: 11752105
Drug: Edrophonium (0.2-0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium (0.2-0.4 mg/kg)
Trial: 11752105
Drug: Edrophonium (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium (1.0 mg/kg)
Trial: 804397
Drug: Parenteral carbohydrates
RxNorm normalized name: CARBOHYDRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral carbohydrates combined with essential amino acids and histidine
Trial: 27661192
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (20 IU)
Trial: 23398227
Drug: Nicotine gum
RxNorm normalized name: Equate Nicotine Gum 4mg Starter Kit
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine gum treatment
Trial: 17188609
Drug: Intravenous Glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Glucose Tolerance Test (IVGTT)
Trial: 12023757
Drug: Polymethylmethacrylate (PMMA)
RxNorm normalized name: methylmethacrylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polymethylmethacrylate (PMMA) implant
Trial: 9855418
Drug: Pneumococcal conjugate
RxNorm normalized name: pneumococcal conjugate PCV 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal conjugate vaccines
Trial: 8011010
Drug: Ketorolac (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac (10 mg every 6 h)
Trial: 8011010
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (50 mg every 8 h)
Trial: 2492166
Drug: Human growth
RxNorm normalized name: Human growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human growth hormone‐releasing factor (GH‐RF) (1 microgram/kg i.v.)
Trial: 1096540
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg per day of temazepam
Trial: 31055542
Drug: Pranayama breathing
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranayama breathing exercises for 15 minutes daily for 1 month
Trial: 21670470
Drug: Fludarabine, cyclophosphamide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludarabine, cyclophosphamide, and rituximab (as salvage therapy)
Trial: 18198776
Drug: Intra-articular injection
RxNorm normalized name: PHOSPHORUS P-32 5 mCi in 1 mL INTRA-ARTICULAR INJECTION, SUSPENSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular injection of tenoxicam 20 mg
Trial: 18198776
Drug: Oral tenoxicam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tenoxicam 20 mg a day for 10 days
Trial: 15051552
Drug: Ginger (1.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger (1.05 g daily for 3 weeks)
Trial: 15051552
Drug: Vitamin B6
RxNorm normalized name: vitamin B6
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B6 (75 mg daily for 3 weeks)
Trial: 9690699
Drug: Flutamide (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (a selective androgen receptor antagonist)
Trial: 7516637
Drug: Cisplatin (DDP)
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin (DDP) 100 mg/mq i.v. on day 1 and 5-fluorouracil (5-FU) 750 mg/mq/day i.v. continuous infusion from days 1 to 4
Trial: 7516637
Drug: Cisplatin (DDP)
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin (DDP) 100 mg/mq i.v. on day 1 and 5-fluorouracil (5-FU) 750 mg/mq/day i.v. continuous infusion from days 1 to 4 with added alpha interferon (IFN-alpha) 3 MU s.c., three times weekly from days 1 to 21
Trial: 7516637
Drug: Cisplatin (DDP)
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin (DDP) and 5-fluorouracil (5-FU) with recombinant granulocyte colony stimulating factor (G-CSF) 5 micrograms/kg b.w. s.c. from days 7 to 18
Trial: 2815647
Drug: Millimetric waves
RxNorm normalized name: ELECTRODE GEL,H-WAVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Millimetric waves treatment
Trial: 31852711
Drug: 3-month dual
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-month dual antiplatelet therapy (DAPT)
Trial: 31888702
Drug: Buzhong Yiqi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buzhong Yiqi decoction plus standard therapy
Trial: 25963758
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate with single dose of calcium gluconate (SBCG1)
Trial: 25963758
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate with double dose of calcium gluconate (SBCG2)
Trial: 16642484
Drug: Treatment at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment at IMIP (Recife, Brazil)
Trial: 16642484
Drug: Treatment at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment at US centers
Trial: 14731162
Drug: Protease inhibitors
RxNorm normalized name: Protease inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitors (ritonavir or indinavir)
Trial: 28547269
Drug: Continuous bladder
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous bladder catheterization (CC)
Trial: 20167144
Drug: Budesonide/formoterol pMDI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol pMDI with actuation counter (80/4.5 micrograms x 2 inhalations [160/9 micrograms] twice daily) - Group 1 (96 actuations, 24 days)
Trial: 20167144
Drug: Budesonide/formoterol pMDI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol pMDI with actuation counter (80/4.5 micrograms x 2 inhalations [160/9 micrograms] twice daily) - Group 2 (120 actuations, 30 days)
Trial: 20167144
Drug: Budesonide/formoterol pMDI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol pMDI with actuation counter (80/4.5 micrograms x 2 inhalations [160/9 micrograms] twice daily) - Group 3 (128 actuations, 32 days)
Trial: 20167144
Drug: Budesonide/formoterol pMDI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol pMDI without actuation counter (80/4.5 micrograms x 2 inhalations [160/9 micrograms] twice daily) - Run-in period
Trial: 18062023
Drug: Combined electric,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined electric, electromagnetic, quantum and microvibration therapy with basic treatment (antiaggregants, beta-blockers, statins)
Trial: 18062023
Drug: Laser therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser therapy with basic treatment (antiaggregants, beta-blockers, statins)
Trial: 18062023
Drug: Basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatment without physiotherapy
Trial: 12134936
Drug: 0.5 ml
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ml of 1% lidocaine injected into the carotid sinus nerve
Trial: 12134936
Drug: No injection
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No injection of lidocaine
Trial: 11574360
Drug: 2.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/kg propofol
Trial: 4061377
Drug: Dexamethasone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (10 mg I.V. before therapy, and 4 mg I.V. q 4 h X 6 doses)
Trial: 30045185
Drug: EXC 001
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EXC 001 (5 mg/cm)
Trial: 20870113
Drug: Intracameral phenylephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracameral phenylephrine 15.0 mg/mL (1.5%)
Trial: 20870113
Drug: Intracameral phenylephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracameral phenylephrine 30.0 mg/mL (3.0%)
Trial: 20870113
Drug: Intracameral phenylephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracameral phenylephrine 0.15 to 5.00 mg/mL (0.015% to 0.500%)
Trial: 16615926
Drug: High-dose magnesium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose magnesium sulfate (50 mg/kg load and 2 g/h)
Trial: 16615926
Drug: Low-dose magnesium
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose magnesium sulfate (25 mg/kg load and 1 g/h)
Trial: 16615926
Drug: High-dose magnesium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose magnesium sulfate
Trial: 16615926
Drug: Low-dose magnesium
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose magnesium sulfate
Trial: 229707
Drug: FOY-305 oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOY-305 oral capsule
Trial: 25752903
Drug: Group BII:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group BII: Initial bolus plus early start of the intermittent infusion
Trial: 25752903
Drug: Group DII:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group DII: No bolus plus delayed start (8 h) of the intermittent infusion
Trial: 23635846
Drug: CBTp (Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBTp (Cognitive Behavioural Therapy) + TAU (Treatment as Usual)
Trial: 10718501
Drug: Placebo (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (for aspirin)
Trial: 9197297
Drug: 2-chloroprocaine 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-chloroprocaine 1% (30 ml)
Trial: 9197297
Drug: 2-chloroprocaine 3%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-chloroprocaine 3% (10 ml)
Trial: 3569828
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml 5% tylose
Trial: 3569828
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml 2.5 mM calcium chloride gel
Trial: 3569828
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml 9.0 mM calcium chloride gel
Trial: 3569828
Drug: calcium chloride
RxNorm normalized name: Calcium Chloride
DrugBank: Calcium chloride (DB01164)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: calcium chloride gel
Trial: 29627621
Drug: Buprenorphine/naloxone (flexible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine/naloxone (flexible take-home doses)
Trial: 29627621
Drug: Methadone (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone (daily witnessed ingestion)
Trial: 12699023
Drug: Behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavior therapy and nicotine patch
Trial: 10226092
Drug: Beta-blockers and
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers and amiodarone
Trial: 10226092
Drug: Beta-blockers alone
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers alone
Trial: 10226092
Drug: Neither beta-blockers
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neither beta-blockers nor amiodarone
Trial: 8688255
Drug: 0.2% ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% ropivacaine at 6 ml h‐1
Trial: 8688255
Drug: 0.2% ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% ropivacaine at 8 ml h‐1
Trial: 8688255
Drug: 0.2% ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% ropivacaine at 10 ml h‐1
Trial: 8688255
Drug: 0.2% ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% ropivacaine at 12 ml h‐1
Trial: 8688255
Drug: 0.2% ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% ropivacaine at 14 ml h‐1
Trial: 8688255
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no postoperative extradural infusion)
Trial: 8688255
Drug: All ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All ropivacaine infusion groups
Trial: 8688255
Drug: Higher ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher ropivacaine infusion rates
Trial: 18774743
Drug: Dopamine agonists
RxNorm normalized name: Dopamine agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine agonists (DA) as monotherapy
Trial: 18774743
Drug: Dopamine agonists
RxNorm normalized name: Dopamine agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine agonists (DA) as adjunctive therapy
Trial: 18774743
Drug: Dopamine agonists
RxNorm normalized name: Dopamine agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine agonists (DA)
Trial: 17335818
Drug: N‐acetyl cysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N‐acetyl cysteine (1.8 g/d)
Trial: 15470328
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg rabeprazole once daily
Trial: 15470328
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg rabeprazole twice daily
Trial: 15470328
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg rabeprazole 4 times daily
Trial: 9678535
Drug: Small iodine
RxNorm normalized name: Iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Small iodine supplements (Thyrojod depot tablets containing 1530 microg iodide) every 2 weeks for 2 years followed by once weekly for 2 years.
Trial: 9678535
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no iodine supplements).
Trial: 9678535
Drug: Small iodine
RxNorm normalized name: Iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Small iodine supplements (Thyrojod depot tablets containing 1530 microg iodide).
Trial: 8034818
Drug: Balanced Deficit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balanced Deficit Diet (BDD) - 1,200-kcal/day diet throughout treatment
Trial: 2648767
Drug: 200‐300 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200‐300 mg/day of trazodone
Trial: 2648767
Drug: 200‐300 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200‐300 mg/day trazodone plus 1 ampoule (1000 gamma of lipidic phosphorous) twice daily of hypothalamic phospholipids (HPL)
Trial: 22390966
Drug: Disease targeting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease targeting therapies (DTT)
Trial: 22390966
Drug: Escalation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escalation of therapy
Trial: 19389004
Drug: Sildenafil 100
RxNorm normalized name: sildenafil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 100 mg on-demand 0.75-2 hours before sexual stimulation
Trial: 16774799
Drug: Elemental oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elemental oral nutrition supplements
Trial: 16774799
Drug: Peptide oral
RxNorm normalized name: Fe heme polypeptide Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peptide oral nutrition supplements
Trial: 16774799
Drug: Polymeric oral
RxNorm normalized name: dicresulene polymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polymeric oral nutrition supplements
Trial: 11207404
Drug: Ketorolac 60
RxNorm normalized name: ketorolac 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 60 mg intramuscularly
Trial: 11207404
Drug: Meperidine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 1.5 mg/kg (max 100 mg) intramuscularly
Trial: 9278654
Drug: Aprotinin (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprotinin (loading dose of 2 x 10(6) KI units followed by 0.5 x 10(6) KI units/h)
Trial: 3725504
Drug: Fat emulsion
RxNorm normalized name: FAT EMULSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat emulsion administered at a constant rate for 24 hours, starting at 1 g/kg and increasing to a maximum of 4 g/kg
Trial: 3725504
Drug: Fat emulsion
RxNorm normalized name: FAT EMULSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat emulsion administered at a constant rate for 16 hours, starting at 1 g/kg and increasing to a maximum of 4 g/kg
Trial: 3725504
Drug: Fat emulsion
RxNorm normalized name: FAT EMULSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat emulsion administered at a constant rate of 4 g/kg for 24 hours
Trial: 3725504
Drug: Infusion rates
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Infusion rates as used in the study
Trial: 3725504
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of fat at a constant rate for 24 hours
Trial: 26698676
Drug: Fertility medication
RxNorm normalized name: Tests for fertility disturbances
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fertility medication (selective estrogen receptor modulator, gonadotropin, or other) or infertility treatment (IVF or IUI)
Trial: 24584875
Drug: Standard external
RxNorm normalized name: CATHETER,EXTERNAL STANDARD BARD #150503
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard external beam radiation therapy (EBRT)
Trial: 20926027
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin C (0.06 g/kg bolus followed by 0.02 g/kg)
Trial: 12196880
Drug: Parenteral oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Parenteral oxytocin (5 units i.v. or 10 units i.m.)
Trial: 10223249
Drug: CA125 elevation
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CA125 elevation (> or =30 U/mL)
Trial: 10223249
Drug: CA125 <30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CA125 <30 U/mL
Trial: 2129633
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg omeprazole o.m.